FDA.reportPublic FDA data

vosoritide 0.56 MG Injection

RxCUI
2586371
RxNorm name
vosoritide 0.56 MG Injection
Display name
vosoritide 0.56 MG Injection
Full name
vosoritide 0.56 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VOXZOGO 0.4mgVOSORITIDEBioMarin Pharmaceutical Inc.228e8560-04a4-4bb1-a81f-29531a9e4d272025-11-25Warnings, Adverse reactionsExact identifier
rxcui: 2586371

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
228e8560-04a4-4bb1-a81f-29531a9e4d27vosoritide 0.56 MG Injection [PSN] · vosoritide 0.56 MG Injection [SCD]216These highlights do not include all the information needed to use VOXZOGO safely and effectively. See full prescribing information for VOXZOGO. VOXZOGO (vosoritide) for injection, for subcutaneous use Initial U.S. Approval: 202120251125